Concepedia
Statistics
Publications
10
Citations
664
H-Index
Active since
1990
Affiliations
Massachusetts General Hospital(Current)
Harvard University
Guardant (United States)
University of Massachusetts Chan Medical School
Sara E. Stevens is an author at Massachusetts General Hospital specializing in medicine, oncology, and molecular oncology.
Publications per year
1990–2021
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer
Ibiayi Dagogo‐Jack, Satoshi Yoda, Jochen K. Lennerz et al. · Clinical Cancer Research · 2020 · 194 citations · Full text
Medicine, Oncology, Pharmacology +17
Tracking the Evolution of Resistance to ALK Tyrosine Kinase Inhibitors Through Longitudinal Analysis of Circulating Tumor DNA
Ibiayi Dagogo‐Jack, A. Rose Brannon, Lorin A. Ferris et al. · JCO Precision Oncology · 2018 · 131 citations · Full text
Medicine, Molecular Biology, Oncology +17
Clinical Activity of Alectinib in Advanced RET -Rearranged Non–Small Cell Lung Cancer
Elizabeth A. Kennedy, Lecia V. Sequist, Priscilla K. Brastianos et al. · Journal of Thoracic Oncology · 2016 · 103 citations
Medicine, Oncology, Pharmacology +14
Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR -Mutant Lung Cancer Harboring De Novo MET Amplification
Justin F. Gainor, Matthew J. Niederst, Jochen K. Lennerz et al. · Journal of Thoracic Oncology · 2016 · 81 citations
A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor
Ibiayi Dagogo‐Jack, Philicia Moonsamy, Justin F. Gainor et al. · Journal of Thoracic Oncology · 2021 · 63 citations · Full text
Medicine, Oncology, Pharmacology +9
1–5 of 10